Click Therapeutics and Boehringer Ingelheim partner to develop and market a digital therapeutic to treat schizophrenia

By SharpBrains | September 21, 2020

Boehringer Ingel­heim, Click Ther­a­peu­tics ink $500M+ dig­i­tal ther­a­peu­tics devel­op­ment, com­mer­cial­iza­tion deal (Mobi­Health­News): Inter­na­tion­al phar­ma Boehringer Ingel­heim and pre­scrip­tion dig­i­tal ther­a­peu­tics com­pa­ny Click Ther­a­peu­tics have inked a $500 mil­lion-plus deal to joint­ly devel­op and com­mer­cial­ize a dig­i­tal treat­ment for patients with schizophrenia.

Read More

Neuroengineering meets neuroethics to address treatment-resistant depression

By SharpBrains | November 8, 2019

___________________ Is This the Future of Men­tal Health? (USC Viter­bi School of Engi­neer­ing): “Brain–machine inter­faces (BMIs) pro­vide a direct path­way to the brain to trans­late brain sig­nals into actions … Below, Shanechi (Note: Maryam Shanechi, PhD, assis­tant pro­fes­sor of elec­tri­cal and com­put­er engi­neer­ing) answers some ques­tions about her work and what the future might hold…

Read More

Study: Psychedelics can promote neural plasticity in the prefrontal cortex and expand pathways for mental health

By SharpBrains | August 17, 2018

Psy­che­delics in Neu­rol­o­gy: Poten­tial for Improv­ing Neu­ro­plas­tic­i­ty (Neu­rol­o­gy­Times): “Back in the 1950s, research was prov­ing that psy­che­del­ic agents could be effec­tive in the treat­ment of var­i­ous neu­ropsy­chi­atric dis­or­ders. Unfor­tu­nate­ly, just as sci­ence was explor­ing their ben­e­fi­cial effects, the coun­ter­cul­ture was explor­ing and embrac­ing their effects. Slow­ly but sure­ly, psy­che­delics were asso­ci­at­ed with rebel­lious youth and…

Read More

Mental health meets the digital revolution: Mindstrong Health raises $14 million to modernize the diagnosis and treatment of neuropsychiatric disorders via artificial intelligence (AI) and smartphones

By SharpBrains | June 19, 2017

— Mind­strong Health Rais­es $14 Mil­lion in Series‑A Fund­ing (press release): “Mind­strong Health, a start­up trans­form­ing the diag­no­sis and treat­ment of neu­ropsy­chi­atric dis­or­ders through the pow­er of AI and ubiq­ui­tous mobile tech­nol­o­gy, today announced that it has secured a $14 mil­lion round of Series‑A fund­ing. Led by Fore­site Cap­i­tal and ARCH Ven­ture Part­ners, the round…

Read More